Development asset linked to Chengdu University of in public FDA and regional records. Mechanism: Mu opioid receptor agonist.
- Mechanism
- Mu opioid receptor agonist
pharma · Diarrhea-predominant Irritable Bowel Syndrome
Chengdu University of
Chengdu University of Traditional Chinese Medicine
Chengdu University of drug portfolio — 1 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
CN HQ
256 Employees
NMPA registrant Type
Company details
- Status
- Public
- HQ
- CN
- Employees
- 256
- Programs
- 1
- Drugs
- 1
- Patents
- 0
Chengdu University of pipeline
Portfolio lens on 1 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.
Chengdu University of drug portfolio — 1 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.